Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
D-(+)-chiro-Inositol
(26002642 | 643-12-9)
CAS: | 643-12-9 |
---|---|
Formule moléculaire: | C6H12O6 |
Masse moléculaire: | 180.16 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
26002642-1g | 1g | £30.90 | |
Commande en vrac |
26002642-1g | 1g | €43.30 | |
Commande en vrac |
26002642-1g | 1g | $46.40 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 26002642 | ||||
Product Name | D-(+)-chiro-Inositol | ||||
Categories | Biochemicals Building Blocks Carbohydrates | ||||
CAS | 643-12-9 | ||||
Molecular Formula | C6H12O6 | ||||
Molecular Weight | 180.16 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29061390 EXP 2906139000 IMP |
Spécifications du produit
Lead | 3.0ppm max. | ||||
Total plate count | 10000cfu/g max. | ||||
Loss on Drying | 8.0%max. | ||||
Storage Temperature | +4 ° C | ||||
Molecular Weight | 180.16 | ||||
Assay | 95%min. | ||||
Mercury | 0.1ppm max. | ||||
Appearance | White crystalline powder | ||||
Other inositol | 2%max. |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|